Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/2010
11/18/2010US20100290988 Fluorinated fructose derivatives for pet imaging
11/18/2010US20100290987 Methods and compositions for detecting and modulating o-glycosylation
11/18/2010US20100290986 Therapeutic use of diaminophenothiazines
11/18/2010US20100290985 Macromolecular compositions that cross the blood-brain barrier and methods of use thereof
11/18/2010US20100290984 Anti-mrp3 antibodies and methods of use
11/18/2010US20100290983 Compositions and Methods for Drug Delivery
11/18/2010US20100290982 Solid in oil/water emulsion-diffusion-evaporation formulation for preparing curcumin-loaded plga nanoparticles
11/17/2010EP2250504A2 Use of fsh receptor ligands for diagnosis and therapy of cancer
11/17/2010EP2249879A2 Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix
11/17/2010EP1027080B1 Method for detection of fibrin clots
11/17/2010CN1927400B Biomagnetism nano target anti-cancer drug and its preparation
11/17/2010CN101885744A Preparation method of 99mTc labeled hydrazinonicotinamide group-pteroyllysine coordination compound
11/17/2010CN101884818A Suction administration system
11/16/2010US7833525 Crystals of whole antibodies and fragments thereof and methods for making and using them
11/15/2010CA2666069A1 Fluorinated fructose derivatives for pet imaging
11/11/2010WO2010129572A2 Pet radiotracers for imaging fatty acid metablolism and storage
11/11/2010WO2010128595A1 Method for producing radioactive iodine-labeled imidazopyridine derivative
11/11/2010WO2009141091A8 Novel [f-18] -labelled l-glutamic acid- and l-glutamine derivatives (i), use thereof and method for their production
11/11/2010US20100286512 Systems, methods and apparatus for preparation, delivery and monitoring of radiopharmaceuticals
11/11/2010US20100286375 Carrier molecules
11/11/2010US20100285510 Marker for inflammatory conditions
11/11/2010US20100284914 Novel Amine-Borane Compounds and Uses Thereof
11/11/2010US20100284913 Methods and compositions for studying, imaging, and treating pain
11/11/2010US20100284912 Homogenization of a radiopharmaceutical using sonification and/or rotor-stator technology to produce a homogenous suspension, emulsion, mixture or solid suspension of immiscible ingredients
11/11/2010US20100284911 Preparations and methods for treating malignancies
11/11/2010US20100284910 Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers
11/11/2010US20100284909 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
11/11/2010US20100284908 Proteins
11/11/2010US20100284907 Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells
11/11/2010US20100284906 Internalizing Anti-CD74 Antibodies and Methods of Use
11/11/2010US20100284905 Methods and Agents for Inhibiting Tumor Growth by Targeting the SSDNA Replication Intermediate of Tumor Stem Cells
11/11/2010CA2760334A1 Pet radiotracers for imaging fatty acid metabolism and storage
11/10/2010EP2247620A1 Anti-cd79b antibodies and immunoconjugates and methods of use
11/10/2010EP2247316A2 Imaging the central nervous system
11/10/2010EP1590007B1 Improved radiometal complex compositions
11/10/2010EP1545525B1 Radiolabeled neurokinin-1 receptor antagonists
11/10/2010CN101880873A Preparation process of 103Pd sealed seed source core
11/10/2010CN101401944B Method of preparing iodine-125 sealing seed source core
11/10/2010CN101130555B **TC*N nucleus marked dithiocarbamate complex, preparing method and application of the same
11/09/2010US7829672 Modulation of sodium channels in dorsal root ganglia
11/09/2010US7829064 antigen binding molecules conjugated to lipids, polymer carriers, micelles, nanoparticles or mixtures and effectors, used for therapy of diagnosis
11/09/2010US7829063 Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
11/09/2010CA2161684C Bioactive and/or targeted dendrimer conjugates
11/04/2010WO2010127054A2 Imaging tumor perfusion, oxidative metabolism using dynamic ace pet in patients with head and neck cancer during radiotherapy
11/04/2010WO2010126279A2 Cytokeratin 17-specific human antibody
11/04/2010WO2010125647A1 Radioactively labeled substance
11/04/2010WO2010125068A2 Labeled molecular imaging agents, methods of making and methods of use
11/04/2010WO2010092111A3 Compounds for non-invasive measurement of aggregates of amyloid peptides
11/04/2010US20100280232 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/04/2010US20100280177 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/04/2010US20100278736 FLT4 (VEGFR-3) as a Target for Tumor Imaging and Anti-Tumor Therapy
11/04/2010US20100278733 Composition for diagnosis of amyloid-related disease
11/04/2010US20100278732 1h-[1, 2, 3] triazole substituted amino acids and uses thereof
11/04/2010US20100278731 Mechanism-Based Targeted Pancreatic Beta Cell Imaging and Therapy
11/04/2010US20100278730 Non-Invasive Molecular Imaging of Cellular Histone Deacetylase Substrate Using Magnetic Resonance Spectroscopy (MRS) or Positron Emission Tomography (PET)
11/04/2010US20100278729 Breast cancer eradication program
11/04/2010US20100278728 Anti-Mullerian Inhibiting Substance Type II Receptor (MISIIR) Immunoconjugates to Detect and Treat Cancer
11/04/2010US20100278727 Alpha-Emitting constructs and uses thereof
11/04/2010US20100278726 Modified Antibodies to Prostate-Specific Membrane Antigen and Uses Thereof
11/04/2010US20100278725 Methods and devices for lymphatic targeting
11/04/2010US20100278724 Inhibition of migration and induction of cell death by the type ii collagen amino propeptides
11/04/2010CA2759000A1 Labeled molecular imaging agents, methods of making and methods of use
11/03/2010EP2246070A2 Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b
11/03/2010EP2244742A2 Therapy selection method
11/03/2010EP2244729A1 Cysteine engineered antibodies for site-specific conjugation
11/03/2010EP2009443B1 Diagnostic agent and therapeutic agent for pancreatic cancer
11/03/2010EP1841790B1 Ephb receptor-binding peptides
11/03/2010CN101878213A Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
11/03/2010CN101874899A Medicine for developing dopamine transporter and preparation method thereof
11/02/2010US7825219 Binding protein; therapy for bone tumors
11/02/2010US7825095 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
11/02/2010US7825087 Nanoparticulate and controlled release compositions comprising cyclosporine
11/02/2010US7825086 Acyclovir-peptide analogs
11/02/2010US7824660 boron neutron capture therapy, attaching antibody (IgG) cell-targeting species to BN nanostructures to form composite, administering to target tumors, activating boron in composite; indirect source of radiation therapy, delivery vehicles for radio- and chemo-therapeutic materials, imaging agents
11/02/2010US7824659 2-tert-Butyl-4-chloro-5-[4-(2-[18F]-fluoro-ethoxymethyl)-benzyloxy]-2H-pyridazin-3-one used as Positron Emission Tomography (PET) radiolabeled tracers
10/2010
10/28/2010WO2010060104A3 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone praticles as scaffolds for tissue regeneration
10/28/2010WO2009141090A8 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them
10/28/2010US20100274052 Preparation of radiolabelled haloaromatics via polymer-bound intermediates
10/28/2010US20100273724 Pegylated ion channel modulating compounds
10/28/2010US20100272645 Myocardial perfusion imaging method
10/28/2010US20100272644 Complexation of fatty acid-conjugated molecules with albumin
10/28/2010US20100272643 Procaspase 8-Mediated Disease Targeting
10/28/2010US20100272642 Pet probe having an alkoxy group substituted by fluorine and hydroxy group
10/28/2010US20100272641 Labeled molecular imaging agents, methods of making and methods of use
10/28/2010US20100272640 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
10/28/2010US20100272639 Polysaccharide nanoparticles
10/28/2010US20100272638 Radiolabelled microparticles, processes for the preparation thereof and the use thereof
10/28/2010US20100272636 Anti-CD74 Immunoconjugates and Methods of Use
10/28/2010US20100272635 Methods and compositions for diagnosis and/or prognosis in ovarian cancer and lung cancer
10/27/2010EP1658282B1 Novel chelating agents and chelates and their use
10/26/2010US7820621 also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis
10/26/2010US7820410 Proteins with high immunoreactivity and method for their production
10/26/2010US7820390 Methods of and kits and compositions for diagnosing colorectal tumors
10/26/2010US7820164 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; colon cancer
10/26/2010US7820161 Treatment of autoimmune diseases
10/26/2010CA2284733C Motilin homologs
10/21/2010WO2010121153A2 Biocompatible microbubbles to deliver radioactive compounds to tumors, atherosclerotic plaques, joints and other targeted sites
10/21/2010WO2010120368A2 Stabilization of radiopharmaceutical compositions using ascorbic acid
10/21/2010WO2010119389A2 Pretargeting kit, method and agents used therein
10/21/2010WO2010119382A1 Pretargeting kit, method and agents used therein
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 243